Bio-IT World March 28, 2024
Joseph La Barge, CEO of Apertura Gene Therapy, began his career raising capital and building biotech companies. At Spark Therapeutics he served as both Chief Legal and Chief Business Officer overseeing business development, patient advocacy, quality assurance, legal affairs, compliance, finance, public policy, and global pricing and reimbursement. In 2019, La Barge led the negotiation of Spark’s acquisition by Roche and stayed until 2022. Today he leads Apertura Gene Therapy, helping his team find effective treatments for patients through gene expression and capsid engineering. In the newest episode of Trends from the Trenches, host Stan Gloss speaks with La Barge about his unique perspective on growing biotech businesses. La Barge delves into the challenges he and his team face...
Today's Sponsors
Today's Sponsor